Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
3.
Clin Nutr ; 25(2): 245-59, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16697500

ABSTRACT

Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility of increasing or ensuring nutrient intake in cases where normal food intake is inadequate. These guidelines are intended to give evidence-based recommendations for the use of ONS and TF in cancer patients. They were developed by an interdisciplinary expert group in accordance with officially accepted standards, are based on all relevant publications since 1985 and were discussed and accepted in a consensus conference. Undernutrition and cachexia occur frequently in cancer patients and are indicators of poor prognosis. EN should be started if undernutrition already exists or if food intake is markedly reduced for more than 7-10 days. Standard formulae are recommended for EN. Nutritional needs generally are comparable to non-cancer subjects. In cachectic patients metabolic modulators such as progestins, steroids and possibly eicosapentaenoic acid may help to improve nutritional status. EN is indicated preoperatively for 5-7 days in cancer patients undergoing major abdominal surgery. During radiotherapy of head/neck and gastrointestinal regions dietary counselling and ONS prevent weight loss and interruption of radiotherapy. Routine EN is not indicated during (high-dose) chemotherapy.


Subject(s)
Cachexia/therapy , Enteral Nutrition/standards , Malnutrition/therapy , Medical Oncology/standards , Practice Patterns, Physicians' , Cachexia/etiology , Enteral Nutrition/methods , Europe , Humans , Malnutrition/etiology , Neoplasms/complications
4.
Nutrition ; 17(2): 91-4, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11240334

ABSTRACT

This study assessed the feasibility and effectiveness of jejunal feeding (JF) after surgery due to secondary peritonitis or failed conservative therapy of severe pancreatitis. Of 60 patients, 30 were randomly assigned to receive postoperative JF and the remaining 30 constituted the control group. Acute Physiology and Chronic Health Evaluation II, nutritional intake, systemic inflammatory response syndrome, and outcomes were measured. Patients in JF group received the daily mean of 1294.6 (362.6) kcal including 830.6 (372.7.0) kcal enterally, versus 472.8 (155.8) kcal daily in the control group (P < 0.0001). There were fewer complications in the JF patients, with no significant difference; length of stay in the intensive care unit and in the hospital did not differ. The frequency of systemic inflammatory response syndrome was similar in both groups, but outcomes differed. The first surgical intervention resulted in 3.3% of relaparotomies in JF patients, caused by unresolved peritonitis, versus 26.7% in the control subjects (P = 0.03). Recovery of bowel transit took significantly less time in the JF patients (mean: 54.6 h versus 76.8 h in control subjects, P = 0.01). JF resulted in 3.3% mortality as opposed to 23.3% in the control group (P = 0.05). In conclusion, JF is feasible and effective in postoperative treatment of patients due to secondary peritonitis or severe pancreatitis. Improved bowel and peritoneal function could be the main impact of JF.


Subject(s)
Enteral Nutrition , Pancreatitis/therapy , Peritonitis/therapy , Adolescent , Adult , Aged , Enteral Nutrition/methods , Female , Humans , Inflammation , Jejunum , Length of Stay , Male , Middle Aged , Pancreatitis/mortality , Peritonitis/mortality , Postoperative Care , Prospective Studies , Survival Analysis , Time Factors
5.
Vet Hum Toxicol ; 42(6): 341-4, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11111939

ABSTRACT

Three extracts originating from a combination of various Latvian plant species were tested for their antibacterial activities by evaluating growth delays using a fully automated microturbidimetric method. Ten different human and bovine strains of the genera Staphylococcus and Micrococcus were used as test microorganisms. The inhibitory effect in vitro was defined as the difference between the growth rate without herbs and the growth rate in the presence of an extract. Among the tested strains, Staphylococcus aureus was found sensitive to all 3 extracts. However, extract I was the most effective in slowing the growth of all strains tested. Using appropriate tester strains it should be possible to set up a broad-range microtubidimetry assay for individual herb screening in vitro. The hemolytic effects of the individual extracts on human erythrocytes were also studied at different concentrations. Two of the herbal extracts had minimal lytic effects on eurocaryotic cells. An additional hemolysis test was conducted in the presence of coenzyme Q10 (CoQ10) as a free radical scavenger: CoQ10 had no effect on the hemolytic reaction.


Subject(s)
Magnoliopsida/microbiology , Micrococcus luteus/drug effects , Plant Extracts/pharmacology , Plants, Medicinal/microbiology , Staphylococcus aureus/drug effects , Xanthenes , Animals , Cattle , Colony Count, Microbial , Erythrocytes/drug effects , Fluorometry , Hemolysis/drug effects , Humans , Indicators and Reagents/pharmacology , Latvia , Least-Squares Analysis , Magnoliopsida/therapeutic use , Micrococcus luteus/growth & development , Nephelometry and Turbidimetry , Oxazines/pharmacology , Phytotherapy , Plant Extracts/therapeutic use , Plants, Medicinal/therapeutic use , Staphylococcus aureus/growth & development , Ubiquinone/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...